Edwards Lifesciences answers US FTC complaint against JenaValve Technology deal
MLex Summary: Edwards Lifesciences submitted answers to the US Federal Trade Commission's complaint against its merger with JenaValve Technology. The company argues that the agency can't show that the transaction would harm...To view the full article, register now.
Already a subscriber? Click here to view full article